TD Asset Management Inc. reduced its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 9.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 344,021 shares of the pharmacy operator’s stock after selling 36,010 shares during the quarter. TD Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $18,808,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Family Legacy Inc. boosted its position in Walgreens Boots Alliance by 2.5% during the 1st quarter. Family Legacy Inc. now owns 8,020 shares of the pharmacy operator’s stock worth $442,000 after acquiring an additional 195 shares during the period. Plimoth Trust Co. LLC boosted its position in Walgreens Boots Alliance by 2.4% during the 1st quarter. Plimoth Trust Co. LLC now owns 8,379 shares of the pharmacy operator’s stock worth $530,000 after acquiring an additional 200 shares during the period. Cable Hill Partners LLC boosted its position in Walgreens Boots Alliance by 40.0% during the 1st quarter. Cable Hill Partners LLC now owns 700 shares of the pharmacy operator’s stock worth $44,000 after acquiring an additional 200 shares during the period. Exencial Wealth Advisors LLC boosted its position in Walgreens Boots Alliance by 1.0% during the 1st quarter. Exencial Wealth Advisors LLC now owns 20,134 shares of the pharmacy operator’s stock worth $1,274,000 after acquiring an additional 207 shares during the period. Finally, Hammer Asset Management LLC boosted its position in Walgreens Boots Alliance by 0.6% during the 1st quarter. Hammer Asset Management LLC now owns 38,043 shares of the pharmacy operator’s stock worth $2,407,000 after acquiring an additional 214 shares during the period. Hedge funds and other institutional investors own 61.97% of the company’s stock.
Several brokerages have recently weighed in on WBA. Bank of America cut their price objective on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a report on Monday, June 3rd. Morgan Stanley set a $61.00 price objective on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Tuesday, May 14th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, June 28th. JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a report on Friday, June 28th. Finally, Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective for the company. in a report on Monday, June 10th. Six investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $63.82.
In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the company’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the completion of the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 15.73% of the company’s stock.
Shares of NASDAQ WBA opened at $50.48 on Friday. Walgreens Boots Alliance Inc has a 12 month low of $49.12 and a 12 month high of $86.31. The company has a market cap of $45.53 billion, a price-to-earnings ratio of 8.33, a P/E/G ratio of 1.26 and a beta of 0.81. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49. The business has a fifty day simple moving average of $54.18 and a 200-day simple moving average of $57.57.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating the consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The business had revenue of $34.59 billion during the quarter, compared to the consensus estimate of $34.52 billion. During the same period in the prior year, the business posted $1.53 earnings per share. Walgreens Boots Alliance’s revenue was up .7% compared to the same quarter last year. As a group, sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be issued a dividend of $0.458 per share. This represents a $1.83 annualized dividend and a dividend yield of 3.63%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Monday, August 19th. Walgreens Boots Alliance’s dividend payout ratio is currently 29.24%.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: Equity Income
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.